1 / 5

Contraceptives Drugs And Devices Market

Contraceptive drugs and devices that aid to control birth rate and unintended pregnancies are subject to unique regulatory challenges across different countries. For instance, contraceptive drugs and devices face reimbursement challenges in the U.S., while contraceptive pills face advertising restrictions in India.

akshay925
Download Presentation

Contraceptives Drugs And Devices Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Contraceptives Drugs And Devices Market Contraceptives Drugs And Devices Market Size,Trends,Shares,Insights,Forecast,2024-Coherent Market Size,Trends,Shares,Insights,Forecast,2024-Coherent Market Insights Insights Contraceptives can be used after sex to stop a pregnancy before it starts. There are two main types of emergency contraception: Emergency contraceptive pills (ECPs) and copper T intrauterine device (IUD). The global contraceptives market is estimated to account for US$ 25,969.2 Mn in terms of value in 2020 and is expected to reach US$ 37,889.0 Mn by the end of 2027. Global Contraceptives Market: Drivers Global Contraceptives Market: Drivers Increasing population is expected to propel growth of the global emergency contraceptives market over the forecast period. For instance, according to projections by Population Reference Bureau (PRB) included in the 2018 World Population Data Sheet, the world population is expected to reach 9.9 billion by 2050, up 2.3 billion or 29% from an estimated 7.6 billion people in 2018. Moreover, increasing focus on family planning among the populace is also expected to aid in growth of the market. For instance, according to PRB’s 2019 Family Planning Data Sheet, globally, 62% of married women ages 15 to 49 use a method of family planning and 56% use a modern method. Devices held dominant position in the global contraceptives market in 2019, accounting for 57.2% share in terms of value, followed by drugs, respectively

  2. Get PDF Brochure Of This Research Report @ Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/365 https://www.coherentmarketinsights.com/insight/request-pdf/365 Global Contraceptives Market: Restraints Global Contraceptives Market: Restraints Side effects associated with the use of contraceptive drugs and devices are expected to hinder growth of the global contraceptives market. Long term side effects associated with oral contraceptive pills such as increased risk of breast cancer, blood clots, and heart strokes strongly discourage usage. Moreover, low adoption of emergency contraceptives in emerging economies is expected to hinder growth of the market. For instance, according to PRB’s 2019 Family Planning Data Sheet, fewer than 15% of married women of reproductive age use a modern contraceptives in Democratic Republic of the Congo. Global Contraceptives Market: Opportunities Global Contraceptives Market: Opportunities Increasing rate of literacy is expected to offer lucrative growth opportunities for players in the global contraceptives market. For instance, according to United Nations Children's Fund, globally, the youth literacy rate increased from 83% to 91% during 1985-2018. Moreover, high prevalence of HIV/AIDS is expected to boost demand for contraceptives. For instance, according to UNAIDS Global HIV & AIDS statistics — 2019 fact sheet, 37.9 million people were infected with HIV worldwide. The global contraceptives market was valued at US$ 24,605.4 Mn in 2019 and is forecast to reach a value of US$ 37,889.0 Mn by 2027 at a CAGR of 5.5% between 2020 and 2027.

  3. Research Methodology Research Methodology Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include: Primary Research (Trade Surveys and Experts Interviews) Primary Research (Trade Surveys and Experts Interviews) • Desk Research Desk Research • Proprietor Data Analytics Model Proprietor Data Analytics Model • In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings. Request Sample Copy of Research Report @ Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/365 https://www.coherentmarketinsights.com/insight/request-sample/365 Market Trends/Key Takeaways Market Trends/Key Takeaways Major contraceptive drugs are nearing patent expiry, which is expected to make way for generics. For instance, patent for YAZ (drospirenone/ethinylestradiol), which provides an oral contraceptive regimen, is set to expire in 2021.

  4. Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in February 2020, Agile Therapeutics, Inc. received the U.S. Food and Drug Administration (FDA) approval for its Twirla (levonorgestrel and ethinyl estradiol) transdermal system indicated as a method of contraception for use in women. Global Contraceptives Market: Competitive Landscape Global Contraceptives Market: Competitive Landscape Major players operating in the global emergency contraceptives market include, Evofem Biosciences, Inc., Actavis Generics (Teva Pharmaceutical Industries Ltd.), Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Uniprix, Gavis Pharmaceuticals (Lupin Limited), Sandoz International GmbH, Aurobindo Pharma Limited, HRA Pharma, SA, Mankind Pharma, Merck & Co, Bayer HealthCare AG, Church & Dwight, Co. Inc., Allergan, Pfizer, Inc., Agile Therapeutics Inc., BioSante Pharmaceuticals Inc., Mayer Laboratories, Inc., and Pantarhei Bioscience B.V. Global Contraceptives Market: Key Developments Global Contraceptives Market: Key Developments Major players in the market are focused on raising funds to expand their product portfolio. For instance, in April 2020, Evofem Biosciences, Inc. entered into a private Securities Purchase Agreement with a U.S.-based, healthcare-focused institutional investor for up to US$ 25 million of convertible notes. About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

  5. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com

More Related